Novonesis stock sees largest gain in a decade following strong earnings

Novonesis has reported strong second-quarter financial results, leading to a significant surge in its stock price. The company achieved a profit of 179.4 million euros and revenue of 1,116.2 million euros, exceeding analyst expectations.

Driven largely by increased demand in the food and beverage sector for healthier food solutions and simpler ingredient lists, the biotechnology group has raised its organic revenue growth guidance for the remainder of the year to 7-8 percent, up from the previous estimate of 5-7 percent.

Following these results, Novonesis's stock topped the Danish C25 index, rising by more than ten percent. This represents the company's largest single-day stock gain in over a decade, with the last comparable increase occurring in October 2015.